# Essure (Model ESS310) Placement Rate Study

> **NCT02064413** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 134 (actual)

## Conditions studied

- Contraception

## Interventions

- **DEVICE:** ESS310 (BAY1454032)

## Key facts

- **NCT ID:** NCT02064413
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-17
- **Primary completion:** 2014-10-02
- **Final completion:** 2014-11-26
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2021-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02064413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02064413, "Essure (Model ESS310) Placement Rate Study". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02064413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*